top of page
Search

Medical Morphine Market, Global Outlook and Forecast 2023-2032

  • Writer: Siddhi Patil
    Siddhi Patil
  • Sep 22, 2023
  • 4 min read

The global Medical Morphine market was valued at US$ 11280 million in 2022 and is projected to reach US$ 13160 million by 2029, at a CAGR of 2.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.


Morphine is a pain medication of the opiate variety which is found naturally in a number of plants and animals. It acts directly on the central nervous system (CNS) to decrease the feeling of pain. It can be taken for both acute pain and chronic pain. It is frequently used for pain from myocardial infarction and during labour. It can be given by mouth, by injection into a muscle, by injecting under the skin, intravenously, into the space around the spinal cord, or rectally. Maximum effect is around 20 minutes when given intravenously and 60 minutes when given by mouth, while duration of effect is 3?7 hours. Long-acting formulations also exist.

Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-medical-morphine-forecast-2023-2032-114


This report aims to provide a comprehensive presentation of the global market for Medical Morphine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Morphine. This report contains market size and forecasts of Medical Morphine in global, including the following market information:

Global Medical Morphine Market Revenue, 2018-2023, 2024-2032, ($ millions)

Global Medical Morphine Market Sales, 2018-2023, 2024-2032, (K Units)

Global top five Medical Morphine companies in 2022 (%)

The increasing prevalence of arthritis and cancer in geriatric patients is projected to impact the morphine market globally positively. The global medical morphine market is consolidated in nature owing to the dominance of few companies in manufacturing and processing. Morphine production is regulated by stringent regulation policies passed by several countries which would hamper its manufacturing. North America dominated the global medical morphine market and is expected to maintain its position in global market attributed to its increasing consumption in the U.S.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medical Morphine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Medical Morphine Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)

Global Medical Morphine Market Segment Percentages, by Type, 2022 (%)


  • Oral

  • Injectables

Global Medical Morphine Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)

Global Medical Morphine Market Segment Percentages, by Application, 2022 (%)


  • Cancer

  • Arthritis

Global Medical Morphine Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)

Global Medical Morphine Market Segment Percentages, By Region and Country, 2022 (%)


  • North America

  • US

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Russia

  • Nordic Countries

  • Benelux

  • Rest of Europe

  • Asia

  • China

  • Japan

  • South Korea

  • Southeast Asia

  • India

  • Rest of Asia

  • South America

  • Brazil

  • Argentina

  • Rest of South America

  • Middle East & Africa

  • Turkey

  • Israel

  • Saudi Arabia

  • UAE

  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:


  • Key companies Medical Morphine revenues in global market, 2018-2023 (Estimated), ($ millions)

  • Key companies Medical Morphine revenues share in global market, 2022 (%)

  • Key companies Medical Morphine sales in global market, 2018-2023 (Estimated), (K Units)

  • Key companies Medical Morphine sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:


  • Mallinckrodt Pharmaceuticals

  • Alcaliber

  • Purdue Pharma

  • Pfizer

  • Sun Pharmaceutical Industries

  • Taj Pharmaceuticals Limited

Outline of Major Chapters:


Chapter 1: Introduces the definition of Medical Morphine, market overview.

Chapter 2: Global Medical Morphine market size in revenue and volume.

Chapter 3: Detailed analysis of Medical Morphine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Medical Morphine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Medical Morphine capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

CONTACT US:

276 5th Avenue, New York , NY 10001,United States

International: (+1) 646 781 7170

 
 
 

Recent Posts

See All

Comments


bottom of page